Mindera Health Collaborates with the University of Pennsylvania for Academic Research Exploring Cutaneous Lupus Erythematosus Treatment
The research pairs Mindera Health’s Dermal Biomarker Patch™ and Subtilitas Platform with Penn’s translational immunology expertise to decode quinacrine’s mechanism of action in treatment-resistant cutaneous lupus. Vista, CA, Sept. 09, 2026 (GLOBE NEWSWIRE) — Mindera Health™, a leader in precision medicine for dermatological conditions, today announced a research